免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

NCT:NCT03617458 · COMPLETED

NCT IDNCT03617458
狀態COMPLETED
開始日期2018-08-23
完成時間2025-08-19
SponsorVanderbilt University Medical Center (OTHER)
First posted
Last updated

簡要摘要

The primary objective of this study is to determine the impact of two interventions against insulin resistance on the composite endpoint of 10% improvement in baseline six minute walk distance or improvement in World Health Organization (WHO) functional class in humans with pulmonary artery hypertension (PAH).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑